A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

Please discuss the class and complete drug profile of amyloid-targeting therapies for Alzheimer disease, including their mechanisms of action, efficacy, and safety profiles.

Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) occurs when lymphocytes called T cells and B cells become ...

A prospective, single-arm, phase II study (41) conducted at Peking Union Medical College Hospital in China included 9 patients with IVLBCL, who received zanubrutinib combined with R-CHOP (rituximab ..

In addition, we were pleased to see Phase 2 IIT indolent lymphoma data presented at ... single-agent drugs with complementary mechanisms of action will yield additive or synergistic efficacy ...

Under the microscope, the cells look just like the cancerous T cells found in anaplastic large cell lymphoma (ALCL ... with the CD20 antigen on the surface of the cells include: Rituxan (rituximab) ...

In January 2023, positive data was presented from the ongoing clinical Phase I/IIa study of BI-1206 in combination with rituximab for the treatment of non-Hodgkin’s lymphoma (NHL). Data suggest ...

Rituxan (rituximab) is not safe to receive while pregnant or breastfeeding. Certain factors, including the risk of fetal harm, may determine whether you should receive Rituxan treatment during ...

What are the greatest 2000s action movies of all time? It's a tricky question to answer, as, in the new millennium, action cinema was undergoing serious evolution. Across a long and tumultuous ...